Clinical Trial Results for Sjögren’s Syndrome Treatment

This case study explores the early clinical trial results of CFZ533, a novel treatment for Sjögren’s syndrome, highlighting the challenges of diagnosis and the significance of targeting the disease's underlying mechanisms. Rheumatologist Benjamin Fisher discusses the trial's findings and the potential for future therapies to improve patient outcomes.